How ABRYSVO can help protect you from lung disease caused by RSV
Get to know the ABRYSVO vaccine
ABRYSVO is a vaccine developed by Pfizer that can help prevent disease of the lower respiratory tract (lungs) caused by RSV. It is given to individuals 60 years of age and older.
ABRYSVO is a bivalent vaccine and can help protect against both RSV Subgroup A and RSV Subgroup B.
As with any vaccine, ABRYSVO will not protect 100% of those who receive it. ABRYSVO is not a treatment for RSV infection or its complications.
How ABRYSVO works
You will receive
ONE
DOSE
of abrysvo
How ABRYSVO works
The vaccine works by helping your body to make the antibodies (the substances your body uses to fight an infection) that help protect against RSV.
Note that ABRYSVO does not contain an adjuvant (a substance added to some vaccines to help the body produce an immune response).
Talk to your healthcare provider about ABRYSVO at your next appointment.
What are the possible side effects of ABRYSVO?
ABRYSVO was given to
17,215
older adults during the Phase 3 trial
The most common side effects reported among older adults were pain, redness, or swelling where the injection was given.
Like all vaccines, ABRYSVO can cause side effects, although not everyone experiences them.
Be sure to tell your healthcare professional if you have known allergies to any of the following substances: mannitol, polysorbate 80, sodium chloride, sucrose, tromethamine, trometamol hydrochloride.
ABRYSVO is a vaccine to help prevent disease of the lower respiratory tract (lungs) caused by RSV (respiratory syncytial virus). ABRYSVO is given to pregnant individuals (from 32 through 36 weeks’ gestation) to protect their infants from birth through 6 months of age, and individuals 60 years of age and older. As with any vaccine, ABRYSVO will not protect 100% of those who receive it. ABRYSVO is not a treatment for RSV infection or its complications. Like all vaccines, ABRYSVO can cause side effects, although not everybody gets them.
For more information, please consult the Product Monograph or call 1-800-463-6001.